Sonoma Pharmaceuticals, Inc.
(NASDAQ : OCLS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MDCOThe Medicines Co.
0.31%84.1620.1%$581.68m
AMRNAmarin Corp. Plc
0.62%21.951.7%$313.85m
VRXValeant Pharmaceuticals International, Inc.
-0.59%28.7814.1%$169.35m
BHCBausch Health Cos., Inc.
-0.55%28.790.0%$100.69m
JAZZJazz Pharmaceuticals Plc
1.10%149.732.3%$100.49m
GWPHGW Pharmaceuticals Plc
-2.61%100.826.2%$99.06m
SAGESAGE Therapeutics, Inc.
7.26%64.558.6%$77.03m
ICPTIntercept Pharmaceuticals, Inc.
-8.93%109.0916.9%$76.49m
PRGOPerrigo Co. Plc
1.26%52.466.8%$70.86m
AXSMAxsome Therapeutics, Inc.
3.03%44.552.0%$53.44m
HZNPHorizon Therapeutics Plc
1.73%32.416.6%$45.49m
ICLRICON plc
1.09%163.164.2%$44.15m
ENDPEndo International Plc
1.14%4.888.8%$35.39m
UTHRUnited Therapeutics Corp.
1.60%91.6714.3%$34.01m
MYOKMyoKardia, Inc.
0.78%67.652.1%$30.24m

Company Profile

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.